View the SERITO registration information details.
Back to drug list
ItemsDrug Registration information
ID2924
No2924
Brand NameSERITO
IngredientsITOPRIDE HYDROCHLORIDE 50 MG
Dosage FormTABLET
Primary PackagingALU-PVC BLISTER
Storage
Shelf Life2 YEARS
Pack SizeBOX OF 1 X 10'S
Dispensing Category
ATC Classification
Pharmaceutical Class
IndicationsFOR TREATMENT OF GASTROINTESTINAL SYMPTOMS OF FUNCTIONAL, NON ULCER DYSPEPSIA SUCH AS FEELING OF ABDIMINAL BLOATENESS, EXCESSIVE FEELING OF FULL NESS IN THE STOMACH, UPPER ABDOMINAL PAIN, DISCOMFORT, ANOREXIA, HEARTBURN, NAUSEA AND VOMITING.
Contraindications
Side Effects
Unit Price
EDLNULL
DescriptionWHITE TO ALMOST WHITE, ROUND, BICONVEX FILM COATED TABLET
Note
License OwnerXUPTHAVYKHOUN SOLE CO.,LTD
ManufacturerSERAPH PHARMACEUTICAL
CountryPAKISTAN
Import Registration No
Import Registration Date
ActivityCERTIFICATE RELEASED
Applied Date
FDD Registration No02 I 5895/25
FDD Registration Date45712
Expiry Date47537
Back to drug list
ADB ASEAN COVID-19 Laos JICA KOICA Global Fund WFP UHS Laos World Bank MOH Laos UNODC WHO SIDA